A previous study on colon cancer showed that the concurrence of KRAS and PIK3CA mutations in cells induced the potential synergistic hyperactivation of the RAS/ERK and PI3K/AKT pathways, which result in uncontrolled cell proliferation and metastasis [26]. This evidence concerns the gene KRAS and colonic neoplasm.